Market Overview:
The global endometrial cancer treatment market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of endometrial cancer, increasing awareness about early diagnosis and treatment options, and technological advancements in the field of endometrial cancer treatment. Based on type, the global market for endometrial cancer treatment is segmented into chemotherapy and surgical treatments. Chemotherapy is further sub-segmented into hormone therapy and cytotoxic therapy. Surgical treatments are further sub-segmented into laparoscopic surgery and open surgery. Based on application, the market is segmented into hospitals and clinics. Geographically, the global market for endometrial cancer treatment is segmented into North America, Latin America, Europe Asia Pacific ,and Middle East & Africa .
Product Definition:
Endometrial cancer treatment is the process of curing or managing endometrial cancer. Treatment options vary depending on the stage and severity of the cancer. Common treatments include surgery, radiation therapy, and chemotherapy.
Chemotherapy:
Chemotherapy is a group of medical treatment used to treat cancer. Chemotherapy includes drugs, biologics, and monoclonal antibodies. The most common types of cancers treated with chemotherapy include breast cancer, lung cancer, colorectal cancer prostate cancer and lymphoma among others.
Surgical:
Surgical ablation is a minimally invasive procedure used to remove the lining of female reproductive organs. It is also known as endometrial ablation or uterine ablation and involves cutting, burning, freezing or vaporizing the endometrium (the thin layer of tissue that lines a woman's uterus) in order to prevent blood from pooling there and cause an infection.
Application Insights:
Based on application, the global endometrial cancer treatment market is segmented into hospital-based and clinic-based. The hospital-based segment dominated the overall market in terms of revenue in 2017 owing to availability of advanced healthcare facilities with highly skilled manpower across major countries. Moreover, increasing number of hospitals offering comprehensive healthcare services along with a high standard of living has resulted in growth over past few years.
The Clinic based segment is expected to grow at a lucrative rate during the forecast period due to rising awareness about early diagnosis and effective treatment methods for endometrial cancer patients as well as increased government funding for research related initiatives that focus on improving access to quality care through clinics & hospitals at an affordable cost.
Regional Analysis:
North America dominated the global endometrial cancer treatment market in 2017. This can be attributed to the high incidence of this disease, increasing government funding for research & development, and rising awareness campaigns by various organizations. For instance, in October 2016, Merck KGaA launched a campaign called “It's On Us†to raise awareness about sexual assault and encourage bystander action against it. The company also established a USD X million fund with an aim to support on-campus initiatives that help prevent sexual violence among students. Asia Pacific is expected to witness lucrative growth over the forecast period owing to improving healthcare infrastructure and growing patient affordability coupled with rising disposable income levels in emerging economies such as China & India.
Major players operating in this industry include but are not limited too; Johnson & Johnson Services Inc.
Growth Factors:
- Increasing incidence of endometrial cancer
- Rising awareness about early detection and treatment of endometrial cancer
- Growing demand for minimally invasive surgical procedures for the treatment of endometrial cancer
- Technological advancements in the field of endometrial cancer treatment
- increasing number of clinical trials for novel therapies for the treatment of endometrial cancer
Scope Of The Report
Report Attributes
Report Details
Report Title
Endometrial Cancer Treatment Market Research Report
By Type
Chemotherapy, Surgical
By Application
Hospital, Clinic
By Companies
Ariad, Abbott, BD, GlaxoSmithKline, Merck, Novartis, Sanofi, Siemens, Roche, Ariad
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
168
Number of Tables & Figures
118
Customization Available
Yes, the report can be customized as per your need.
Global Endometrial Cancer Treatment Market Report Segments:
The global Endometrial Cancer Treatment market is segmented on the basis of:
Types
Chemotherapy, Surgical
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Ariad
- Abbott
- BD
- GlaxoSmithKline
- Merck
- Novartis
- Sanofi
- Siemens
- Roche
- Ariad
Highlights of The Endometrial Cancer Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Chemotherapy
- Surgical
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Endometrial Cancer Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Endometrial cancer is a type of cancer that occurs in the lining of the uterus (endometrium). The endometrium is a layer of tissue that covers the inside of the uterus. Endometrial cancer can grow and spread to other parts of the body. Treatment for endometrial cancer may include surgery, chemotherapy, and radiation therapy.
Some of the major players in the endometrial cancer treatment market are Ariad, Abbott, BD, GlaxoSmithKline, Merck, Novartis, Sanofi, Siemens, Roche, Ariad.
The endometrial cancer treatment market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Endometrial Cancer Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Endometrial Cancer Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Endometrial Cancer Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Endometrial Cancer Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Endometrial Cancer Treatment Market Size & Forecast, 2018-2028
4.5.1 Endometrial Cancer Treatment Market Size and Y-o-Y Growth
4.5.2 Endometrial Cancer Treatment Market Absolute $ Opportunity
Chapter 5 Global Endometrial Cancer Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Endometrial Cancer Treatment Market Size Forecast by Type
5.2.1 Chemotherapy
5.2.2 Surgical
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Endometrial Cancer Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Endometrial Cancer Treatment Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Endometrial Cancer Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Endometrial Cancer Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Endometrial Cancer Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Endometrial Cancer Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Endometrial Cancer Treatment Market Size Forecast by Type
9.6.1 Chemotherapy
9.6.2 Surgical
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Endometrial Cancer Treatment Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Endometrial Cancer Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Endometrial Cancer Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Endometrial Cancer Treatment Market Size Forecast by Type
10.6.1 Chemotherapy
10.6.2 Surgical
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Endometrial Cancer Treatment Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Endometrial Cancer Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Endometrial Cancer Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Endometrial Cancer Treatment Market Size Forecast by Type
11.6.1 Chemotherapy
11.6.2 Surgical
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Endometrial Cancer Treatment Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Endometrial Cancer Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Endometrial Cancer Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Endometrial Cancer Treatment Market Size Forecast by Type
12.6.1 Chemotherapy
12.6.2 Surgical
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Endometrial Cancer Treatment Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Endometrial Cancer Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Endometrial Cancer Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Endometrial Cancer Treatment Market Size Forecast by Type
13.6.1 Chemotherapy
13.6.2 Surgical
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Endometrial Cancer Treatment Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Endometrial Cancer Treatment Market: Competitive Dashboard
14.2 Global Endometrial Cancer Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Ariad
14.3.2 Abbott
14.3.3 BD
14.3.4 GlaxoSmithKline
14.3.5 Merck
14.3.6 Novartis
14.3.7 Sanofi
14.3.8 Siemens
14.3.9 Roche
14.3.10 Ariad
